ArticleFrontiers in oncology2026

ctDNA-guided precision therapy with trastuzumab deruxtecan plus pyrotinib in HER2-positive breast cancer brain metastases: a case report.

Danyang Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.